|
US2386796A
(en)
|
1942-08-05 |
1945-10-16 |
Bond Crown & Cork Co |
Extruding device
|
|
DE2855719A1
(de)
|
1978-12-22 |
1980-07-10 |
Siemens Ag |
Zahnaerztliche handstueckanordnung
|
|
US4336336A
(en)
|
1979-01-12 |
1982-06-22 |
President And Fellows Of Harvard College |
Fused gene and method of making and using same
|
|
AU545912B2
(en)
|
1980-03-10 |
1985-08-08 |
Cetus Corporation |
Cloned heterologous jive products in bacillies
|
|
ZA811368B
(en)
|
1980-03-24 |
1982-04-28 |
Genentech Inc |
Bacterial polypedtide expression employing tryptophan promoter-operator
|
|
NZ199722A
(en)
|
1981-02-25 |
1985-12-13 |
Genentech Inc |
Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
|
|
ES8306797A1
(es)
|
1981-04-29 |
1983-06-01 |
Biogen Nv |
Un metodo para producir un polipeptido.
|
|
US4551433A
(en)
|
1981-05-18 |
1985-11-05 |
Genentech, Inc. |
Microbial hybrid promoters
|
|
US4405712A
(en)
|
1981-07-01 |
1983-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
LTR-Vectors
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US4876197A
(en)
|
1983-02-22 |
1989-10-24 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
|
CA1341116C
(en)
|
1983-02-22 |
2000-10-17 |
Rae Lyn Burke |
Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein
|
|
JPS59166086A
(ja)
|
1983-03-09 |
1984-09-19 |
Teruhiko Beppu |
新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法
|
|
US4546083A
(en)
|
1983-04-22 |
1985-10-08 |
Stolle Research & Development Corporation |
Method and device for cell culture growth
|
|
US4588684A
(en)
|
1983-04-26 |
1986-05-13 |
Chiron Corporation |
a-Factor and its processing signals
|
|
JPS59205983A
(ja)
|
1983-04-28 |
1984-11-21 |
ジエネツクス・コ−ポレイシヨン |
異種遺伝子を原核微生物で発現させる方法
|
|
US4663280A
(en)
|
1983-05-19 |
1987-05-05 |
Public Health Research Institute Of The City Of New York |
Expression and secretion vectors and method of constructing vectors
|
|
EP0127839B1
(en)
|
1983-05-27 |
1992-07-15 |
THE TEXAS A&M UNIVERSITY SYSTEM |
Method for producing a recombinant baculovirus expression vector
|
|
US4689406A
(en)
|
1983-08-10 |
1987-08-25 |
Amgen |
Enhancement of microbial expression of polypeptides
|
|
US4870008A
(en)
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
|
JPS6054685A
(ja)
|
1983-09-02 |
1985-03-29 |
Suntory Ltd |
改良発現ベクタ−およびその利用
|
|
EP0136907A3
(en)
|
1983-10-03 |
1986-12-30 |
Genentech, Inc. |
A xenogeneic expression control system, a method of using it, expression vectors containing it, cells transformed thereby and heterologous proteins produced therefrom
|
|
ZA848495B
(en)
|
1984-01-31 |
1985-09-25 |
Idaho Res Found |
Production of polypeptides in insect cells
|
|
US4880734A
(en)
|
1984-05-11 |
1989-11-14 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
|
EP0164556B1
(en)
|
1984-05-11 |
1994-03-02 |
Chiron Corporation |
Enhanced yeast transcription employing hybrid promoter region constructs
|
|
CA1282721C
(en)
|
1984-06-04 |
1991-04-09 |
Bernard Roizman |
Herpes simplex virus as a vector
|
|
US5288641A
(en)
|
1984-06-04 |
1994-02-22 |
Arch Development Corporation |
Herpes Simplex virus as a vector
|
|
US4738921A
(en)
|
1984-09-27 |
1988-04-19 |
Eli Lilly And Company |
Derivative of the tryptophan operon for expression of fused gene products
|
|
US4745056A
(en)
|
1984-10-23 |
1988-05-17 |
Biotechnica International, Inc. |
Streptomyces secretion vector
|
|
US4837148A
(en)
|
1984-10-30 |
1989-06-06 |
Phillips Petroleum Company |
Autonomous replication sequences for yeast strains of the genus pichia
|
|
US4762915A
(en)
|
1985-01-18 |
1988-08-09 |
Liposome Technology, Inc. |
Protein-liposome conjugates
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
EP0196056B1
(en)
|
1985-03-28 |
1991-05-22 |
Chiron Corporation |
Improved expression using fused genes providing for protein product
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4865974A
(en)
|
1985-09-20 |
1989-09-12 |
Cetus Corporation |
Bacterial methionine N-terminal peptidase
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
JPS6296086A
(ja)
|
1985-10-21 |
1987-05-02 |
Agency Of Ind Science & Technol |
複合プラスミド
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5091309A
(en)
|
1986-01-16 |
1992-02-25 |
Washington University |
Sindbis virus vectors
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
EP0244042B1
(en)
|
1986-05-02 |
1994-08-17 |
Gist-Brocades N.V. |
Secretory signal selection vectors for extracellular protein synthesis in bacilli
|
|
JP2612874B2
(ja)
|
1986-10-02 |
1997-05-21 |
マサチユセツツ・インスチチユート・オブ・テクノロジー |
タンパク質の代謝的安定性を調節する方法
|
|
JPS63123383A
(ja)
|
1986-11-11 |
1988-05-27 |
Mitsubishi Kasei Corp |
ハイブリツドプロモ−タ−、発現調節ｄｎａ配列および発現ベクタ−
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
DK175243B1
(da)
|
1987-03-23 |
2004-07-19 |
Zymogenetics Inc |
Ekspressionsvektor, der er i stand til at styre ekspression af heterologe gener eller cDNA i gær, gærværtscelle samt fremgangsmåde til öget produktion af proteiner i gærværtsceller
|
|
US4980289A
(en)
|
1987-04-27 |
1990-12-25 |
Wisconsin Alumni Research Foundation |
Promoter deficient retroviral vector
|
|
WO1989001973A2
(en)
|
1987-09-02 |
1989-03-09 |
Applied Biotechnology, Inc. |
Recombinant pox virus for immunization against tumor-associated antigens
|
|
DK463887D0
(da)
|
1987-09-07 |
1987-09-07 |
Novo Industri As |
Gaerleader
|
|
EP0633318A1
(en)
|
1987-09-11 |
1995-01-11 |
Whitehead Institute For Biomedical Research |
Transduced fibroblasts and uses therefor
|
|
US4929555A
(en)
|
1987-10-19 |
1990-05-29 |
Phillips Petroleum Company |
Pichia transformation
|
|
WO1989004669A1
(en)
|
1987-11-18 |
1989-06-01 |
Chiron Corporation |
Nanbv diagnostics and vaccines
|
|
WO1989005349A1
(en)
|
1987-12-09 |
1989-06-15 |
The Australian National University |
Method of combating viral infections
|
|
CA1340772C
(en)
|
1987-12-30 |
1999-09-28 |
Patricia Tekamp-Olson |
Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
|
|
US4973551A
(en)
|
1988-01-15 |
1990-11-27 |
Merck & Co., Inc. |
Vector for the expression of fusion proteins and protein immunogens
|
|
CH684094A5
(de)
|
1988-03-21 |
1994-07-15 |
Viagene Inc |
Rekombinante Retroviren.
|
|
US5591624A
(en)
|
1988-03-21 |
1997-01-07 |
Chiron Viagene, Inc. |
Retroviral packaging cell lines
|
|
US5662896A
(en)
|
1988-03-21 |
1997-09-02 |
Chiron Viagene, Inc. |
Compositions and methods for cancer immunotherapy
|
|
US5206152A
(en)
|
1988-04-08 |
1993-04-27 |
Arch Development Corporation |
Cloning and expression of early growth regulatory protein genes
|
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
WO1990002806A1
(en)
|
1988-09-01 |
1990-03-22 |
Whitehead Institute For Biomedical Research |
Recombinant retroviruses with amphotropic and ecotropic host ranges
|
|
US5217879A
(en)
|
1989-01-12 |
1993-06-08 |
Washington University |
Infectious Sindbis virus vectors
|
|
WO1990007936A1
(en)
|
1989-01-23 |
1990-07-26 |
Chiron Corporation |
Recombinant therapies for infection and hyperproliferative disorders
|
|
EP0448650A4
(en)
|
1989-02-01 |
1992-05-13 |
The General Hospital Corporation |
Herpes simplex virus type i expression vector
|
|
JP3140757B2
(ja)
|
1989-02-06 |
2001-03-05 |
デイナ・フアーバー・キヤンサー・インステイテユート |
パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用
|
|
WO1990011361A1
(en)
|
1989-03-17 |
1990-10-04 |
E.I. Du Pont De Nemours And Company |
External regulation of gene expression
|
|
DE69034078T2
(de)
|
1989-03-21 |
2004-04-01 |
Vical, Inc., San Diego |
Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
DE4091460T1
(enExample)
|
1989-08-15 |
1992-06-25 |
|
|
|
EP1645635A3
(en)
|
1989-08-18 |
2010-07-07 |
Oxford Biomedica (UK) Limited |
Replication defective recombinant retroviruses expressing a palliative
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
GB8919607D0
(en)
|
1989-08-30 |
1989-10-11 |
Wellcome Found |
Novel entities for cancer therapy
|
|
AU7007491A
(en)
|
1990-02-02 |
1991-08-08 |
Schweiz. Serum- & Impfinstitut Bern |
Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
|
|
ZA911974B
(en)
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
|
CA2039921A1
(en)
|
1990-04-16 |
1991-10-17 |
Xandra O. Breakefield |
Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
|
|
AU7906691A
(en)
|
1990-05-23 |
1991-12-10 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5149655A
(en)
|
1990-06-21 |
1992-09-22 |
Agracetus, Inc. |
Apparatus for genetic transformation
|
|
JPH06500923A
(ja)
|
1990-09-21 |
1994-01-27 |
カイロン コーポレイション |
パッケージング細胞
|
|
WO1992007945A1
(en)
|
1990-10-30 |
1992-05-14 |
Dana Farber Cancer Institute |
Cell type specific alteration of levels of gene products in neural cells
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
SE9003978D0
(sv)
|
1990-12-13 |
1990-12-13 |
Henrik Garoff |
Dna expressionssystem baserade paa ett virus replikon
|
|
CA2098849C
(en)
|
1990-12-20 |
2007-07-10 |
Ralph R. Weichselbaum |
Control of gene expression by ionizing radiation
|
|
DK0648271T3
(da)
|
1991-08-20 |
2003-07-21 |
Us Gov Health & Human Serv |
Adenovirusmedieret overførsel af gener til mave-/tarmkanal
|
|
FR2681786A1
(fr)
|
1991-09-27 |
1993-04-02 |
Centre Nat Rech Scient |
Vecteurs recombinants d'origine virale, leur procede d'obtention et leur utilisation pour l'expression de polypeptides dans des cellules musculaires.
|
|
NZ244306A
(en)
|
1991-09-30 |
1995-07-26 |
Boehringer Ingelheim Int |
Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
|
|
IL103059A0
(en)
|
1991-09-30 |
1993-02-21 |
Boehringer Ingelheim Int |
Conjugates for introducing nucleic acid into higher eucaryotic cells
|
|
US6100380A
(en)
*
|
1991-10-28 |
2000-08-08 |
Cytran, Inc. |
Immunomodulating peptides and methods of use
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
|
EP0625049A4
(en)
|
1992-01-23 |
1995-07-12 |
Vical Inc |
EX VIVO GENTRANSFER.
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
EP0650370A4
(en)
|
1992-06-08 |
1995-11-22 |
Univ California |
METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
|
|
WO1993025698A1
(en)
|
1992-06-10 |
1993-12-23 |
The United States Government As Represented By The |
Vector particles resistant to inactivation by human serum
|
|
CA2139847C
(en)
*
|
1992-07-07 |
2002-05-21 |
Akio Matsuhisa |
Probe for diagnosing infectious disease
|
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
|
NZ256018A
(en)
|
1992-09-25 |
1997-07-27 |
Rhone Poulenc Rorer Sa |
Recombinant adenoviral vectors and their use in directing expression and transcription of selected nucleotide sequences in cells of the central nervous system
|
|
ATE307212T1
(de)
|
1992-11-18 |
2005-11-15 |
Arch Dev Corp |
Adenovirus-gelenkter gen-transfer zum herz-und glatten vaskulären muskel
|
|
EP1024198A3
(en)
|
1992-12-03 |
2002-05-29 |
Genzyme Corporation |
Pseudo-adenoviral vectors for the gene therapy of haemophiliae
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
RU2068270C1
(ru)
*
|
1993-01-13 |
1996-10-27 |
Научно-исследовательский институт вакцин и сывороток им.И.И.Мечникова |
Антиген менингококков группы в
|
|
DK0647655T3
(da)
*
|
1993-01-23 |
1999-08-23 |
Inmunologia & Genetica Aplic |
Syntetiske peptider og vacciner mod parvovirus
|
|
US5348358A
(en)
|
1993-02-22 |
1994-09-20 |
Selick David A |
Contact lens insertion tool
|
|
DE4311651A1
(de)
|
1993-04-08 |
1994-10-13 |
Boehringer Ingelheim Int |
Virus für den Transport von Fremd-DNA in höhere eukaryotische Zellen
|
|
ES2188612T3
(es)
|
1993-04-22 |
2003-07-01 |
Skyepharma Inc |
Liposomas multivesiculares de ciclodextrina para encapsular compuestos farmacologicos y metodos para su uso.
|
|
CA2162271A1
(en)
|
1993-05-26 |
1994-12-08 |
Robert Kotin |
Fusion proteins containing adeno-associated virus rep protein and bacterial protein
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
JP3532566B2
(ja)
|
1993-06-24 |
2004-05-31 |
エル． グラハム，フランク |
遺伝子治療のためのアデノウイルスベクター
|
|
BR9405507A
(pt)
|
1993-07-13 |
1999-05-25 |
Rhone Poulenc Rorer Sa |
Adenovirus recombinante defeituoso linhagem celular e composição farmaceutica
|
|
EP0722493A1
(en)
|
1993-07-27 |
1996-07-24 |
THE WISTAR INSTITUTE OF ANATOMY & BIOLOGY |
Modified dna virus vectors and uses therefor
|
|
US5631236A
(en)
|
1993-08-26 |
1997-05-20 |
Baylor College Of Medicine |
Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
|
|
US5362865A
(en)
|
1993-09-02 |
1994-11-08 |
Monsanto Company |
Enhanced expression in plants using non-translated leader sequences
|
|
CA2158937C
(en)
|
1993-09-15 |
2006-01-03 |
Thomas W. Dubensky, Jr. |
Recombinant alphavirus vectors
|
|
FR2710536B1
(fr)
|
1993-09-29 |
1995-12-22 |
Transgene Sa |
Usage anti-cancéreux d'un vecteur viral comportant un gène modulateur de la réponse immunitaire et/ou inflammatoire.
|
|
CA2171109A1
(en)
|
1993-10-01 |
1995-04-13 |
Zvi Ram |
Gene therapy of the nervous system
|
|
DE69435223D1
(de)
|
1993-10-25 |
2009-09-03 |
Canji Inc |
Rekombinanter Adenoviren-Vektor und Verfahren zur Verwendung
|
|
CN1099868C
(zh)
|
1993-11-16 |
2003-01-29 |
斯卡法玛公司 |
具有控制释放活性成分作用的囊
|
|
US5693506A
(en)
|
1993-11-16 |
1997-12-02 |
The Regents Of The University Of California |
Process for protein production in plants
|
|
FR2712603B1
(fr)
|
1993-11-18 |
1996-02-09 |
Centre Nat Rech Scient |
Virus recombinants, préparation et utilisation en thérapie génique.
|
|
JPH07241786A
(ja)
|
1994-03-08 |
1995-09-19 |
Fanuc Ltd |
産業用ロボットの制御装置
|
|
US6780406B1
(en)
|
1994-03-21 |
2004-08-24 |
The Regents Of The University Of Michigan |
Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene
|
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
|
WO1995029993A1
(en)
|
1994-04-28 |
1995-11-09 |
The University Of Michigan |
Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line
|
|
EP0772689B1
(en)
|
1994-05-09 |
2007-12-19 |
Oxford Biomedica (UK) Limited |
Retroviral vectors having a reduced recombination rate
|
|
EP0784690B1
(en)
|
1994-06-10 |
2006-08-16 |
Genvec, Inc. |
Complementary adenoviral vector systems and cell lines
|
|
FR2723588B1
(fr)
|
1994-08-12 |
1996-09-20 |
Rhone Poulenc Rorer Sa |
Adenovirus comprenant un gene codant pour la glutathion peroxydase
|
|
US6245337B1
(en)
*
|
1994-08-25 |
2001-06-12 |
Washington University |
Haemophilus adherence and penetration proteins
|
|
US6121037A
(en)
*
|
1994-10-18 |
2000-09-19 |
Stojiljkovic; Igor |
Bacterial hemoglobin receptor genes
|
|
IL117483A
(en)
*
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
|
AU5741996A
(en)
|
1995-05-22 |
1996-12-11 |
Chiron Corporation |
Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
|
|
US6083499A
(en)
*
|
1996-04-19 |
2000-07-04 |
Mycogen Corporation |
Pesticidal toxins
|
|
CA2264012C
(en)
|
1996-08-13 |
2011-04-26 |
Chiron Corporation |
Compositions and methods for polynucleotide delivery
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
US6583275B1
(en)
*
|
1997-07-02 |
2003-06-24 |
Genome Therapeutics Corporation |
Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics
|
|
US6914131B1
(en)
*
|
1998-10-09 |
2005-07-05 |
Chiron S.R.L. |
Neisserial antigens
|
|
DE69841807D1
(de)
|
1997-11-06 |
2010-09-16 |
Novartis Vaccines & Diagnostic |
Neisseriale antigene
|
|
GB9808866D0
(en)
*
|
1998-04-24 |
1998-06-24 |
Smithkline Beecham Biolog |
Novel compounds
|
|
US6150502A
(en)
*
|
1998-04-29 |
2000-11-21 |
Genesis Research & Development Corporation Limited |
Polypeptides expressed in skin cells
|
|
DE69937419T2
(de)
*
|
1998-05-01 |
2008-07-24 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Neisseria Meningitidis Antigene und Zusammenstellungen
|
|
PT1790660E
(pt)
*
|
2000-02-28 |
2012-09-17 |
Novartis Vaccines & Diagnostic |
Expressão heteróloga de proteínas de neisseria
|
|
GB0121591D0
(en)
*
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|